C14 Ceramide,
N-myristoylsphingosine,
Cer(d18:1/14:0),
N-(Tetradecanoyl)-sphing-4-enine,
C14 Cer,
34227-72-0,
N-Myristoyl-D-sphingosine,
N-(tetradecanoyl)sphing-4-enine,
C14Ceramide,
N-(myristoyl)ceramide,
AC1NQZUS,
N-(myristoyl)-ceramide,
N-tetradecanoylsphingosine,
N-(tetradecanoyl)ceramide,
N-myristoylsphing-4-enine,
N-(tetradecanoyl)-ceramide,
C13916,
N-tetradecanoylsphing-4-enine,
SCHEMBL8797590,
C32H63NO3,
CHEBI:34863,
CHEBI:72957,
N-(Tetradecanoyl)-4-sphingenine,
N-myristoyl-D-erythro-sphingosine,
ZINC8437627,
1645AH,
LMSP02010001,
MFCD01320386,
C14 Ceramide (d18:1/14:0),
N-Myristoyl-D-sphingosine, >=98.0% (TLC),
J-019511,
N-[(E,2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl]tetradecanamide,
N-[(2S,3R,4E)-1,3-dihydroxyoctadec-4-en-2-yl]tetradecanamide,
C14 Ceramide (d18:1/14:0), N-myristoyl-D-erythro-sphingosine, powder,
N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]Tetradecanamide,
N-[2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-, [R-[R*,S*-(E)]]Tetradecanamide,
123408-74-2,
Cer(d32:1),
Cer 32:1,
CID5282310,
34435-05-7,